Clinical Trials

4 enrolled 8 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07280494 2025-12-12

S101MRD

18 enrolled

Lymphoma, Neoplasm, Residual

NCT06649227 2025-12-05

CARLA-M19

Other hematologic neoplasm

5 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT03233854 2025-11-18

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

56 enrolled

Burkitt Lymphoma, Neoplasm, Residual

NCT07053670 2025-11-17

CT1190B

27 enrolled

Lymphoma, B-Cell

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

85 enrolled

Other solid neoplasm

Solid Tumors

NCT04007029 2025-09-05

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT02917083 2025-07-25

RELY-30

60 enrolled

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT04577326 2025-07-25

Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

Other solid neoplasmThoracic

14 enrolled

Mesothelioma, Malignant

NCT05225363 2025-07-01

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

33 enrolled

Gynecologic

Platinum-Resistant Ovarian Carcinoma

NCT03241940 2025-06-29

Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies

33 enrolled

Phase 1 Not yet recruiting

Burkitt Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07043218 2025-06-29

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

36 enrolled

Burkitt Lymphoma

NCT06815029 2025-06-26

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Phase 1 Not yet recruiting

27 enrolled

CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT07032324 2025-06-23

CT1190B

27 enrolled

Lymphoma, B-Cell

NCT03186118 2025-06-17

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03696030 2025-04-13

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms, Meningeal Carcinomatosis

NCT06822868 2025-02-12

CT1190B

Lymphoma, B-Cell

NCT06734871 2025-01-03

CT1190B

Lymphoma, B-Cell

NCT06752785 2024-12-31

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

10 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06724835 2024-12-09

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Phase 1 Not yet recruiting

18 enrolled

Breast

Advanced Breast Cancer

NCT06647329 2024-10-17

CAR-T Therapy

Lymphoma, Recurrence

NCT03448978 2024-07-01

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Phase 1 Terminated

32 enrolled

Plasma cell

Multiple Myeloma

NCT05779917 2024-06-25

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

Pancreatic Neoplasms

NCT05268172 2024-05-16

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

40 enrolled

Thoracic

Pleural Effusion, Malignant

NCT05052528 2024-05-13

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

36 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05420493 2024-01-05

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

54 enrolled

Lymphoma, Non-Hodgkin

NCT05089266 2023-07-17

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

Colorectal Neoplasms

NCT02664363 2023-02-17

ExCeL

Phase 1 Terminated

3 enrolled 8 charts

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT03768310 2022-07-21

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Phase 1 Withdrawn

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05354375 2022-04-29

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Immunotherapy

NCT05043571 2021-09-14

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05038696 2021-09-09

ALaCART

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03423992 2021-06-15

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

100 enrolled

CNS

Glioma, Recurrence

NCT04121273 2021-03-03

GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular

NCT02186860 2021-02-10

Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia

5 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03932565 2020-11-18

Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors

Other solid neoplasm

Nectin4-positive Advanced Malignant Solid Tumor

NCT02757391 2020-10-30

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Phase 1 Terminated

1 enrolled

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies